Can histamine and IgE-driven mast-cell activity amplify neuroimmune inflammation through kynurenine-pathway activation?

Recent neuroimmunological research highlights a sophisticated connection between peripheral allergic signaling and central nervous system pathology, mediated by mast cell degranulation and metabolic pathways.

Mechanistic pathways of neuroinflammation

• Receptor-mediated degranulation: Peripheral allergens cross-link IgE on high-affinity FcεRI receptors on meningeal and parenchymal mast cells, triggering the rapid release of histamine, proteases, and pro-inflammatory cytokines.
• Blood-brain barrier impairment: Mast cell-derived histamine disrupts brain endothelial cell tight junctions—specifically degrading claudin-5 and occludin—increasing blood-brain barrier (BBB) permeability and allowing systemic inflammatory mediators to enter the brain.
• Microglial and astrocytic activation: Histamine binds to H1 and H4 receptors on glial cells, activating downstream MAPK, PI3K/AKT, and NF-κB pathways to drive the production of neurotoxic cytokines like TNF-α and IL-6.

Kynurenine-pathway interactions

• Tryptophan shunting: Chronic mast-cell activation increases indoleamine 2,3-dioxygenase (IDO) activity, depletion of plasma tryptophan, and elevated kynurenine levels, as observed in patients with mastocytosis.
• Feed-forward mast cell sensitization: Kynurenine acts as a direct ligand for the aryl hydrocarbon receptor (AhR) on mast cells. This binding enhances IgE-mediated mast-cell degranulation, leukotriene C₄ release, and cytokine production, forming a continuous metabolic-inflammatory loop.

Bottom line

• Histamine and IgE-driven mast-cell activity directly drives neuroimmune inflammation through blood-brain barrier permeabilization and H1/H4 receptor-dependent glial activation. This neuroinflammatory cascade is reinforced by a bidirectional feedback loop where kynurenine pathway metabolites further sensitize mast cells via aryl hydrocarbon receptor signaling.